ABSTRACT
SUMMARY It is recommended that routine bone scans not be adopted for follow-up of patients with stage I—II breast cancer. Bone scintigraphy should be reserved for evaluation of patients presenting with symptoms suggestive of bone metastases.
- Copyright © 1996 The Cleveland Clinic Foundation. All Rights Reserved.
